Clinical Trial Update: Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer [NA]

View source ↗

Summary

This clinical trial update states that a neoadjuvant chemotherapy regimen combining Caelyx (pegylated liposomal doxorubicin) with paclitaxel for breast cancer h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Caelyx (liposomal doxorubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Breast Cancer | NA | Status: COMPLETED